Drugs / Cordycepin
Cordycepin
also known as
PRaG-1 · 3'-deoxyadenosine · 9-cordyceposidoadenine · Cordycepine · NSC 63984 · NSC-401022
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00003005 | Dec 1997 → Mar 2001 | leukemia | Boston Medical Center | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00709215 | Jun 2008 → Dec 2010 | acute lymphoblastic leukemia | OncoVista, Inc. | Unknown | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT07258160 | Dec 2025 → Jul 2026 overdue | lymphopenia | Second Affiliated Hospital of Soochow University | Recruiting | No outcome recorded |
| Phase 2 | NCT07002502 | Jun 2025 → May 2026 overdue | cancer | Second Affiliated Hospital of Soochow University | Not yet recruiting | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cordycepin | “Cordycepin: The PRaG-1 cordycepin tablets used in this clinical study were produced by Shengmingyuan Company, which is affiliated with the National Bioprocess Engineering...” NCT07258160 ↗ |
| Known as | 3'-deoxyadenosine | ChEMBL registry synonym — accepted as the source's own label CHEMBL305686 ↗ |
| Known as | 9-cordyceposidoadenine | ChEMBL registry synonym — accepted as the source's own label CHEMBL305686 ↗ |
| Known as | Cordycepine | ChEMBL registry synonym — accepted as the source's own label CHEMBL305686 ↗ |
| Known as | NSC 63984 | “A Phase I Study of Cordycepin (NSC 63984) Plus 2'-Deoxycoformycin (NSC 218321) in Patients With Refractory TdT-Positive Leukemia” NCT00003005 ↗ |
| Known as | NSC-401022 | ChEMBL registry synonym — accepted as the source's own label CHEMBL305686 ↗ |
| Known as | PRaG-1 | “Cordycepin: The PRaG-1 cordycepin tablets used in this clinical study were produced by Shengmingyuan Company, which is affiliated with the National Bioprocess Engineering...” NCT07258160 ↗1“The "PRaG-1" cordycepin tablet involved in this clinical study” NCT07002502 ↗ |
| Action | Inhibit | “it served as a poly(A) polymerase inhibitor” PMID 33225826 ↗ Nov 2020 |
| Modality | Small molecule | — CHEMBL305686 ↗ |
| Route | Intravenous | “a 1 hour infusion of cordycepin IV” NCT00003005 ↗ |